Alwyn Capital

Alwyn Capital is an early-stage venture fund investing in underrepresented founders developing biotech innovations that reduce global reliance on animals—a strategic imperative in addressing both climate change and human health challenges. Our team has been at the forefront of investing in transformative companies like Geltor, Blue Nalu, Uncaged Innovations, and Cultured Decadence (acquired by Upside Foods). With deep experience as early investors, we have helped catalyze breakthroughs that leverage biotechnology to tackle some of the world’s most pressing issues while building scalable, sustainable businesses.